RxDoctor Payments Data

Faisal Syed, MD

Clinical Cardiac Electrophysiology · Sanford, NCNPI 1962631499

Payments from drug & device makers

What this record shows

The money is spread across several categories — consulting fees (33.4%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 14 manufacturers reported payments, led by Medtronic at 39.3% of the total. Reporting peaked in 2019 at $14,162 and has fallen 77.1% since, to $3,246 in 2025.

$47,673in general payments, 2019–2025

Across 248 payments — averaging $192.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$19K
  • ZOLL Services LLC (a/k/a ZOLL Lifecor Corp)$9K
  • Boston Scientific$8K
  • Biosense Webster, Inc.$4K
  • Impulse Dynamics (USA) Inc.$3K
  • Biotronik Inc.$2K
  • plus $3K from 8 others
$69,864in research payments, 2019–2025

Across 17 payments — averaging $4109.65 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Boston Scientific$69K
  • Impulse Dynamics (USA) Inc.$448

What the payments were for

  • Consulting fees$15,90033%
  • Speaking & faculty fees$8,75018%
  • Travel & lodging$10,77323%
  • Food & beverage$12,06225%
  • Education$1880%

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$47,673 in reported general payments places this provider in the 70th percentile of 98 clinical cardiac electrophysiology providers in North Carolina.

See all clinical cardiac electrophysiology providers in North Carolina

Medicare billing

Part B allowed, 2024
$157,576
Medicare patients
1,463
Services billed
3,208

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban131$117,954
XareltoRivaroxaban15$23,754
MultaqDronedarone Hcl14$18,306
Metoprolol Succinate86$1,392
Mexiletine Hcl22$1,189
Diltiazem 24hr Er (Cd)Diltiazem Hcl53$532
SotalolSotalol Hcl26$483
Amiodarone Hcl38$357
Colchicine13$261
Spironolactone21$194
Atorvastatin Calcium21$140
Lisinopril11$138
Pantoprazole Sodium18$131
Metoprolol Tartrate22$108
Levothyroxine Sodium11$104

Paid to pharmacies, not to this prescriber.

Other clinical cardiac electrophysiology in Sanford

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →